About CDC’s Progress


Surveillance & Science:

More effective tracking and prevention of healthcare-associated infections, foodborne illness, and gonorrhea (a sexually transmitted infection).

Improved Antibiotic & Antifungal Use:

Improving antibiotic and antifungal use to ensure these drugs are available and work to protect people from life-threatening infections.


Insights for Practice:

Innovations and collaborations with academic and healthcare partners to identify and implement new ways to prevent antimicrobial-resistant infections and their spread in the U.S. and abroad.

Research & Development:

Sharing isolates that inform development of new drugs and diagnostics, and making CDC's sequencing data from antimicrobial-resistant pathogens public to spur innovation in the industry.

Download now: CDC is Innovating to Fight AR

Detection, Response & Containment

Laboratory & Diagnostics:

Gold-standard lab capacity offered to all U.S. state and regional labs through CDC’s AR Laboratory Network, and on-the-ground lab expertise and assistance in some countries abroad.

Epidemiology Capacity for Response:

Increased capacity in state, territorial, and local health departments and some countries for rapid detection and faster response to outbreaks and emerging resistance related to healthcare-associated infections, foodborne bacteria, and gonorrhea (a sexually transmitted infection)—to contain and control spread.

Highlights since 2016

Card image cap

Whole genome sequencing on more than 360,000 germ samples

AR Lab Network has detected about 29,000 resistant germs that required investigation

~$815million distributed to 59 state, territorial, and local health departments

Supporting 500+ local AR experts

Projects in the United States and more than 60 countries abroad